Research study Program year 2025 Source: CMS Open Payments

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 as an Adjunct to Antidepressant Therapies in the Treatment of Subjects with Generalized Anxiety Disorder who have had an Inadequate Response to Antidepressant Therapies

ClinicalTrials.gov NCT06846320

Research payments

$146,626

50 payments

Through program year 2025, $146,626 in research payments was reported against A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 as an Adjunct to Antidepressant Therapies in the Treatment of Subjects with Generalized Anxiety Disorder who have had an Inadequate Response to Antidepressant Therapies, across 50 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT06846320

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$146,626	50

Breakdown

Who paid Research payments · program year 2025

AbbVie, Inc. $146,626 50 payments

Who received the money Research payments · program year 2025

Ima Evaluations Llc Organisation paid for research $4,384 2 payments
Perceptive Pharma Research LLC Organisation paid for research $3,759 1 payment
Viking Clinical Research Organisation paid for research $3,759 1 payment
Global Medical Institutes Organisation paid for research $3,446 1 payment
Barbara Diaz Hernandez Organisation paid for research $3,446 1 payment
Sunwise Clinical Research Organisation paid for research $3,446 1 payment
Sooner Clinical Research INC Organisation paid for research $3,446 1 payment
Northwest Clinical Research Center Organisation paid for research $3,446 1 payment
Erg Clinical Research California Pc Organisation paid for research $3,446 1 payment
Axiom Research LLC Organisation paid for research $3,446 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 as an Adjunct to Antidepressant Therapies in the Treatment of Subjects with Generalized Anxiety Disorder who have had an Inadequate Response to Antidepressant Therapies”, Who Paid My Doc, citing CMS Open Payments, program year 2025. https://www.whopaidmydoc.com/research-studies/a-phase-2-multicenter-randomized-double-blind-placebo-controlled-parallel-group-fixed-dose-study-to-evaluate-the-efficacy-safety-and-tolerability-of-abbv-932-as-an-adjunct-to-antidepressant-therapies-in-the-treatment-of-subjects-with-generalized-anxiety-disorder-who-have-had-an-inadequate-response-to-antidepressant-therapies-59447376

Figures here may be reproduced with attribution and a link — see for journalists and researchers.